Literature DB >> 26441401

Longitudinal Modeling of the Association Between Transmissible Risk, Affect During Drug Use and Development of Substance Use Disorder.

Ralph E Tarter1, Levent Kirisci, Maureen Reynolds, Michelle Horner, ZuWei Zhai, Irene Gathuru, Michael Vanyukov.   

Abstract

OBJECTIVE: This longitudinal investigation examined the hypothesis that subjective experience during consumption of preferred drugs mediates the association of transmissible risk for substance use disorder (SUD) measured in childhood and adolescence, and SUD diagnosis in adulthood. Transmissible risk denotes the psychological characteristics having intergenerational continuity between parents and their biological children.
METHODS: The transmissible liability index (TLI) was administered to four hundred eighty-three 10 to 12-year-old boys (baseline). Follow-up evaluations were conducted when the boys attained 12-14, 16, 19, and 22 years of age, using age-specific versions of the TLI. Frequency of consumption of the participants' three most preferred drugs, affect on an ordinary day, affect while under influence of the preferred substances, and presence/absence of current SUD were assessed at 22 years of age.
RESULTS: Consumption frequency of preferred drugs among boys mediates the association of transmissible risk during childhood, and adolescence and SUD diagnosis in adulthood. Severity of negative affect on a drug-free day predicts frequency of consumption of preferred drugs, which, in turn, predicts severity of negative affect during the drug use event. Neither affect on a drug-free day nor affect during the drug use event mediates the association of transmissible risk and SUD.
CONCLUSIONS: Affect on drug-free days, and while under influence of preferred substances, covary with consumption frequency; however, affect is not related to transmissible SUD risk or SUD outcome.

Entities:  

Mesh:

Year:  2015        PMID: 26441401      PMCID: PMC4630111          DOI: 10.1097/ADM.0000000000000163

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  24 in total

Review 1.  Drug addiction, dysregulation of reward, and allostasis.

Authors:  G F Koob; M Le Moal
Journal:  Neuropsychopharmacology       Date:  2001-02       Impact factor: 7.853

Review 2.  Liability to substance use disorders: 2. A measurement approach.

Authors:  Michael M Vanyukov; Levent Kirisci; Ralph E Tarter; Howard F Simkevitz; Galina P Kirillova; Brion S Maher; Duncan B Clark
Journal:  Neurosci Biobehav Rev       Date:  2003-10       Impact factor: 8.989

Review 3.  Liability to substance use disorders: 1. Common mechanisms and manifestations.

Authors:  Michael M Vanyukov; Ralph E Tarter; Levent Kirisci; Galina P Kirillova; Brion S Maher; Duncan B Clark
Journal:  Neurosci Biobehav Rev       Date:  2003-10       Impact factor: 8.989

4.  Energy drink consumption and increased risk for alcohol dependence.

Authors:  Amelia M Arria; Kimberly M Caldeira; Sarah J Kasperski; Kathryn B Vincent; Roland R Griffiths; Kevin E O'Grady
Journal:  Alcohol Clin Exp Res       Date:  2010-11-12       Impact factor: 3.455

Review 5.  Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders.

Authors:  R Andrew Chambers
Journal:  Drug Alcohol Depend       Date:  2012-12-29       Impact factor: 4.492

6.  Subjective reactions to cocaine and marijuana are associated with abuse and dependence.

Authors:  Julia D Grant; Jeffrey F Scherrer; Michael J Lyons; Ming Tsuang; William R True; Kathleen K Bucholz
Journal:  Addict Behav       Date:  2005-09       Impact factor: 3.913

7.  Response inhibition moderates the relationship between implicit associations and drinking behavior.

Authors:  Katrijn Houben; Reinout W Wiers
Journal:  Alcohol Clin Exp Res       Date:  2009-01-15       Impact factor: 3.455

8.  Age of alcohol and cannabis use onset mediates the association of transmissible risk in childhood and development of alcohol and cannabis disorders: evidence for common liability.

Authors:  Levent Kirisci; Ralph Tarter; Ty Ridenour; Zu Wei Zhai; Diana Fishbein; Maureen Reynolds; Michael Vanyukov
Journal:  Exp Clin Psychopharmacol       Date:  2012-12-03       Impact factor: 3.157

9.  Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability.

Authors:  Michael M Vanyukov; Levent Kirisci; Lisa Moss; Ralph E Tarter; Maureen D Reynolds; Brion S Maher; Galina P Kirillova; Ty Ridenour; Duncan B Clark
Journal:  Behav Genet       Date:  2009-04-18       Impact factor: 2.805

10.  Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities.

Authors:  M T Tsuang; M J Lyons; J M Meyer; T Doyle; S A Eisen; J Goldberg; W True; N Lin; R Toomey; L Eaves
Journal:  Arch Gen Psychiatry       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.